insights_auto
Waarom is ANW gedaald 33,90%?
Meer informatiechevron_right
ANW:FRA
Immuron Ltd
€ 0,020
arrow_downward
-33,90%(-0,010) 1D
13 okt, 11:46:18 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ANW genereren…
Openen
€ 0,02
Hoog
€ 0,02
Laag
€ 0,02
Beursw.
9,47 mln.
Gem. vol.
627,00
Volume
0,00
52 wk hoog
€ 0,04
52 wk laag
€ 0,01
Aantal medewerkers
8
Openen
€ 0,02
Hoog
€ 0,02
Laag
€ 0,02
Beursw.
9,47 mln.
Gem. vol.
627,00
Volume
0,00
52 wk hoog
€ 0,04
52 wk laag
€ 0,01
Aantal medewerkers
8
Nieuwsartikelen
Van webbronnen en nieuwspartners
Stock Titan
·
10 uur geleden
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
TipRanks
·
21 uur geleden
Immuron advances Travelan after Phase 2 data published in Nature journal
Profiel
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Over Immuron Ltd
CEO-
Medewerkers8
Opgericht1994
HoofdkantoorBlackburn North, Victoria, Australië
Sector-
Websiteimmuron.com.au